Free Trial
NASDAQ:BTCY

Biotricity (BTCY) Stock Price, News & Analysis

$0.75
-0.02 (-2.60%)
(As of 07/26/2024 ET)
Today's Range
$0.75
$0.79
50-Day Range
$0.73
$1.24
52-Week Range
$0.70
$2.98
Volume
23,084 shs
Average Volume
76,471 shs
Market Capitalization
$16.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BTCY stock logo

About Biotricity Stock (NASDAQ:BTCY)

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

BTCY Stock Price History

BTCY Stock News Headlines

“Generational Bull Run” Incoming
LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.
“Generational Bull Run” Incoming
LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.
See More Headlines
Receive BTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
6/27/2024
Today
7/26/2024
Next Earnings (Estimated)
8/12/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:BTCY
Fax
N/A
Employees
55
Year Founded
N/A

Profitability

Net Income
$-14,090,000.00
Net Margins
-116.85%
Pretax Margin
-116.84%

Debt

Sales & Book Value

Annual Sales
$12.06 million
Book Value
($3.34) per share

Miscellaneous

Free Float
19,485,000
Market Cap
$16.24 million
Optionable
Optionable
Beta
1.39
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Dr. Waqaas Al-Siddiq Ph.D. (Age 39)
    Founder, President, CEO & Chairman
    Comp: $732k
  • Mr. S. John Ayanoglou (Age 57)
    Chief Financial Officer
    Comp: $305.75k
  • Mr. Andy Wong
    Vice President of Operations
  • Dr. George N. Nikopoulos
    Director of Business Development
  • Mr. Matt Zabel
    Vice President of Sales & Strategy
  • Mr. Amir Ali
    Chief Development Officer

BTCY Stock Analysis - Frequently Asked Questions

How have BTCY shares performed this year?

Biotricity's stock was trading at $1.15 at the beginning of the year. Since then, BTCY shares have decreased by 34.8% and is now trading at $0.75.
View the best growth stocks for 2024 here
.

How were Biotricity's earnings last quarter?

Biotricity, Inc. (NASDAQ:BTCY) released its quarterly earnings results on Thursday, June, 27th. The company reported ($0.47) EPS for the quarter, missing the consensus estimate of ($0.36) by $0.11. The firm earned $3.18 million during the quarter, compared to the consensus estimate of $3.20 million.

When did Biotricity IPO?

Biotricity (BTCY) raised $15 million in an IPO on Thursday, August 26th 2021. The company issued 5,000,000 shares at a price of $3.00 per share. H.C. Wainwright & Co. served as the underwriter for the IPO.

How do I buy shares of Biotricity?

Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BTCY) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners